Roundup: Recent digital health hires and departures at Merck, MeYou, MDLive, more

By Heather Mack
02:19 am
Share

Rick Lee takes the helm at MeYou Health: Nashville-based employee wellness company Healthways has divested itself from MeYou Health, its Boston-based innovation and digital health subsidiary. Rick Lee, a serial entrepreneur who sold early digital wellness platform Healthrageous to Humana in 2013, led a group of investors, including Ballast Point Ventures, Blue Shield of California, and several prominent individual investors, in an $11 million buyout of the company. Lee will serve as CEO of the newly independent MeYou Health.

Merck exec joins VC firm: Cambridge, Massachusetts-based Flagship Ventures brought on Dr. Michael Rosenblatt as Chief Medical Officer. He will be responsible for leading the company’s internal venture creation team during the conception and launch of new biotech companies. Rosenblatt joins the Flagship from Merck, where he was the company’s first CMO. 

MDLive hires two new execs: Dr. Sylvan Waller will serve as the new Chief Medical Officer. In this position, Dr. Waller will oversee all areas of the company’s medical operations, including physician recruitment and training as well as future medical service strategy. Prior to MDLive, Dr. Waller was founder and CEO of Alii Healthcare, a telehealth company designed to connect patients with ER doctors. Dr. Sanjay Patil will join MDLive as Executive Vice President and General Manager of Health Systems Strategy and Transformation. In this new role, Dr. Patil will oversee healthcare and technology professionals to implement MDLive’s virtual care technology.

Learn on-demand, earn credit, find products and solutions. Get Started >>

Noom hires CSO: Wellness app maker Noom, hired Dr. David Marrero as chief scientific advisor. Marrero is also the president of Diabetes Prevention Program, and his new role will focus on improving the overall counseling and coaching approach of the Noom platform.

Brainscope gets a CCO: Bethesda, Maryland-based neurotechnology company Brainscope appointed Andrew Holman as Chief Commercial Officer. The company focuses on traumatic brain injury and concussion assessment. Holman will lead the commercialization efforts for BrainScope as it prepares to launch its first product – handheld non-invasive instruments designed to aid medical professionals in quickly assessing various neurological conditions.

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!